Michal Mikula

Gliwice Branch
Gliwice, SL, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

Integrated Multi-Omics and Interactome Analysis of CDK8 Inhibition Reveals Erythroid Differentiation Programs and Therapeutic Synergy with BET Blockade in AML.

Integrated Multi-Omics and Interactome Analysis of CDK8 Inhibition Reveals Erythroid Differentiation Programs and Therapeutic Synergy with BET Blockade in AML.

Journal: Cells

Published: June 28, 2026

Gut Microbiota-Metabolite Alterations Associated with Early Metabolic Dysfunction and Hepatic Steatosis in Adolescents.

Gut Microbiota-Metabolite Alterations Associated with Early Metabolic Dysfunction and Hepatic Steatosis in Adolescents.

Journal: Computational and structural biotechnology journal

Published: April 08, 2026

Cancer Without a Map: Navigating Cancer of Unknown Primary Through Molecular Profiling.

Cancer Without a Map: Navigating Cancer of Unknown Primary Through Molecular Profiling.

Journal: Critical reviews in oncology/hematology

Published: April 05, 2026

Metabolomic Study of 7-Ethyl-9-(N-methyl)aminomethyl-10-hydroxycamptothecin Derivative (NMe)-The Chemotherapeutic Drug Candidate Versus Irinotecan (IR) on a Mouse Model.

Metabolomic Study of 7-Ethyl-9-(N-methyl)aminomethyl-10-hydroxycamptothecin Derivative (NMe)-The Chemotherapeutic Drug Candidate Versus Irinotecan (IR) on a Mouse Model.

Journal: Metabolites

Published: January 26, 2026

Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy.

Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy.

Journal: bioRxiv : the preprint server for biology

Published: December 25, 2025

Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts.

Human Fecal Transplantation Modifies the Gut Microbiota but Not Metabolites in Colon Cancer Patient-Derived Xenografts.

Journal: International journal of molecular sciences

Published: December 04, 2025

Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse model.

Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 17, 2025

Feasibility and Diagnostic Accuracy of a Capsule-Sponge Device for Esophageal Squamous Neoplasia (EDEN Trial).

Feasibility and Diagnostic Accuracy of a Capsule-Sponge Device for Esophageal Squamous Neoplasia (EDEN Trial).

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 14, 2025

Genetically Modified Mouse Models for Sarcoma Research: A Comprehensive Review.

Genetically Modified Mouse Models for Sarcoma Research: A Comprehensive Review.

Journal: Current oncology reports

Published: August 15, 2025

Introduction to animal modelling: factors and tools for choosing the optimal model for sarcoma research-a comprehensive literature review.

Introduction to animal modelling: factors and tools for choosing the optimal model for sarcoma research-a comprehensive literature review.

Journal: Translational cancer research

Published: June 09, 2025

Choosing the right animal model for sarcoma research.

Choosing the right animal model for sarcoma research.

Journal: Cellular and molecular life sciences : CMLS

Published: June 07, 2025

The Gut Microbiome Obesity Index: A New Analytical Tool in the Metagenomics Workflow for the Evaluation of Gut Dysbiosis in Obese Humans.

The Gut Microbiome Obesity Index: A New Analytical Tool in the Metagenomics Workflow for the Evaluation of Gut Dysbiosis in Obese Humans.

Journal: Nutrients

Published: June 06, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026